AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Biomedical Innovation for Facial Bone Reconstruction in Oncology: BIOFACE PASS a Medico-economic Study Describing the Standard Pathway of Patients Treated by Free Bone Flap

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Toulouse
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to describe the standard of care pathway of patients treated by free bone flap for facial mandibullar or maxillar reconstruction after surgery for head and neck cancers.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient with oral cavity cancer or maxillary and/or oropharynx cancer * Eligible for treatment by surgery requiring a mandibulectomy or segmental maxillectomy and having a free bone flap for facial reconstruction. * Patient whose disease is classified Stage cT4a, N0 to N3, M0 * Treatment with a feasible curative aim (no contraindication to optimal treatment such as surgery or chemotherapy at a curative dose) * Age greater than or equal to 18 years * Patient affiliated to a Social Security scheme in France * Patient having given written informed consent Non-inclusion Criteria: * Patient having any situation considered by the doctor as a reason for non-inclusion such as stenosis of the leg tripod not allowing reconstruction by fibula, one or more comorbidity(s) not allowing reconstruction by free bone flap or making this reconstruction too much risk * Patient having had previous radiotherapy * Patient with severe coagulation disorders * Patients deprived of liberty or under legal protection regime (curatorship and guardianship, safeguard of justice)
๐Ÿ’Š

What it tests

  • Questionnaires
๐Ÿ“

Where

9 sites
University hospital of Amiens- Picardie
Amiens, France
University hospital of Lille
Lille, France
Hospices Civils de Lyon
Lyon, France
University hospital of Montpellier
Montpellier, France
University hospital of Nantes
Nantes, France
Centre Antoine Lacassagne
Nice, France
University hospital of Rouen
Rouen, France
University hospital of Toulouse
Toulouse, France

โ€ฆand 1 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy